GM
Geoff Meacham B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Amylyx Pharmaceuticals
AMLX
$931M
| $10.44 | $14 |
34%
upside
| Buy |
28 Aug ‘25
11 days ago |
|
2
Vir Biotechnology
VIR
$721M
| $5.19 | $14 |
170%
upside
| Buy |
27 Aug ‘25
12 days ago |
|
3
Acumen Pharmaceuticals
ABOS
$85.4M
| $1.41 | $9 |
538%
upside
| Buy |
25 Aug ‘25
14 days ago |
|
4
Amgen
AMGN
$151B
| $280.19 | $310 |
11%
upside
| Neutral |
6 Aug ‘25
1 month ago |
|
5
Biogen
BIIB
$20.7B
| $141.35 | $135 |
4%
downside
| Neutral |
1 Aug ‘25
1 month ago |
|
6
PTC Therapeutics
PTCT
$4.52B
| $56.95 | $50 |
12%
downside
| Neutral |
28 Jul ‘25
1 month ago |
|
7
CRISPR Therapeutics
CRSP
$4.92B
| $54.10 | $78 |
44%
upside
| Buy |
22 Jul ‘25
1 month ago |
|
8
Royalty Pharma
RPRX
$15.5B
| $35.80 | $42 |
17%
upside
| Buy |
22 Jul ‘25
1 month ago |
|
9
BridgeBio Pharma
BBIO
$10.4B
| $54.29 | $54 |
1%
downside
| Buy |
25 Jun ‘25
2 months ago |
|
10
Protagonist Therapeutics
PTGX
$3.5B
| $56.19 | $72 |
28%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11
NewAmsterdam Pharma
NAMS
$2.83B
| $25.09 | $42 |
67%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
12
Arcellx
ACLX
$3.94B
| $71.11 | $110 |
55%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
|
13
Amylyx Pharmaceuticals
AMLX
$931M
| $10.44 | $12 |
15%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
|
14
Acumen Pharmaceuticals
ABOS
$85.4M
| $1.41 | $4 |
184%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
15
Novavax
NVAX
$1.26B
| $7.73 | $6 |
22%
downside
| Sell |
17 Jun ‘25
2 months ago |
|
16
Avidity Biosciences
RNA
$6.18B
| $48.05 | $75 |
56%
upside
| Buy |
10 Jun ‘25
3 months ago |
|
|
17
Avidity Biosciences
RNA
$6.18B
| $48.05 | $54 |
12%
upside
| Buy |
9 Jun ‘25
3 months ago |
|
18
Regeneron Pharmaceuticals
REGN
$59.2B
| $558.44 | $650 |
16%
upside
| Buy |
2 Jun ‘25
3 months ago |
|
19
AbbVie
ABBV
$371B
| $209.79 | $205 |
2%
downside
| Neutral |
14 May ‘25
3 months ago |
|
20
Kymera Therapeutics
KYMR
$3.09B
| $43.26 | $44 |
2%
upside
| Neutral |
12 May ‘25
3 months ago |
|
21
BioNTech
BNTX
$24.7B
| $102.66 | $140 |
36%
upside
| Buy |
6 May ‘25
4 months ago |
|
22
Neumora Therapeutics
NMRA
$269M
| $1.66 | $1 |
40%
downside
| Underperform |
2 Apr ‘25
5 months ago |
|
23
Moderna
MRNA
$9.66B
| $24.83 | $40 |
61%
upside
| Neutral |
13 Mar ‘25
5 months ago |
|
|
24
Kymera Therapeutics
KYMR
$3.09B
| $43.26 | $52 |
20%
upside
| Buy |
13 Mar ‘25
5 months ago |
|
25
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $36.57 | $40 |
9%
upside
| Buy |
13 Mar ‘25
5 months ago |
|